Inhibition of LOXL2 Enhances the Radiosensitivity of Castration-Resistant Prostate Cancer Cells Associated with the Reversal of the EMT Process

INTRODUCTION: Radiotherapy is the mainstay in the treatment of prostate cancer. However, significant radioresistance of castration-resistant prostate cancer (CRPC) cells constitutes a main obstacle in the treatment of this disease. By using bioinformatic data mining methods, LOXL2 was found to be up...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Peng, Yu, Hongliang, Wang, Feijiang, Yan, Feng, He, Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369494/
https://www.ncbi.nlm.nih.gov/pubmed/30809541
http://dx.doi.org/10.1155/2019/4012590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369494/
https://www.ncbi.nlm.nih.gov/pubmed/30809541
http://dx.doi.org/10.1155/2019/4012590

Ejemplares similares